99 related articles for article (PubMed ID: 30942197)
61. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
[TBL] [Abstract][Full Text] [Related]
62. PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma.
Zhang H; Wang Y; Zhao Y; Liu T; Wang Z; Zhang N; Dai Z; Wu W; Cao H; Feng S; Zhang L; Cheng Q; Liu Z
CNS Neurosci Ther; 2022 Nov; 28(11):1748-1766. PubMed ID: 35855654
[TBL] [Abstract][Full Text] [Related]
63. SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.
Liu Q; Wang XY; Qin YY; Yan XL; Chen HM; Huang QD; Chen JK; Zheng JM
Am J Cancer Res; 2018; 8(4):624-635. PubMed ID: 29736308
[TBL] [Abstract][Full Text] [Related]
64. PSMD12 promotes glioma progression by upregulating the expression of Nrf2.
Wang Z; Li Z; Xu H; Liao Y; Sun C; Chen Y; Sheng M; Lan Q; Wang Z
Ann Transl Med; 2021 Apr; 9(8):700. PubMed ID: 33987398
[TBL] [Abstract][Full Text] [Related]
65. Clinical and prognostic significance of prokineticin 1 in human gliomas.
Xiao B; Tan L; Li D; Wang L; Xiao X; Meng G; Wu Z; Zhang J
Int J Clin Exp Pathol; 2017; 10(7):7661-7669. PubMed ID: 31966611
[TBL] [Abstract][Full Text] [Related]
66. Low Expression of A3C and PLP2 Indicating a Favorable Prognosis in Human Gliomas.
Jin JS; Tsai YL; Chang YC; Tsai WC
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):71-79. PubMed ID: 37715423
[TBL] [Abstract][Full Text] [Related]
67. The role of tumor-associated macrophages in glioma cohort: through both traditional RNA sequencing and single cell RNA sequencing.
Hou Y; Qiu W; Ling Y; Qi X; Liu J; Yang H; Chu L
Front Oncol; 2023; 13():1249448. PubMed ID: 37781198
[TBL] [Abstract][Full Text] [Related]
68. Siglec10-An immunosuppressor and negative predictor of survival prognosis in gliomas.
Wang H; Feng Y; Zhang Y; Wang T; Xu H; Zhi Y; Feng Y; Tian L; Yuan K
Front Genet; 2022; 13():873655. PubMed ID: 36468012
[TBL] [Abstract][Full Text] [Related]
69. Expression and Interactions Between Cell Adhesion Molecules CD44v6 and E-Cadherin in Human Gliomas.
Bar JK; Zub L; Lis-Nawara A; Noga L; Jeleń M; Paradowski B
Adv Clin Exp Med; 2014; 23(5):827-34. PubMed ID: 25491700
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis.
Wu C; Su J; Wang X; Wang J; Xiao K; Li Y; Xiao Q; Ling M; Xiao Y; Qin C; Long W; Zhang F; Pan Y; Xiang F; Liu Q
Cancer Manag Res; 2019; 11():3139-3152. PubMed ID: 31114356
[No Abstract] [Full Text] [Related]
71. Expression and prognostic significance of CTBP2 in human gliomas.
Wang Y; Che S; Cai G; He Y; Chen J; Xu W
Oncol Lett; 2016 Oct; 12(4):2429-2434. PubMed ID: 27698809
[TBL] [Abstract][Full Text] [Related]
72. Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma.
Scuderi SA; Ardizzone A; Salako AE; Pantò G; De Luca F; Esposito E; Capra AP
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730589
[TBL] [Abstract][Full Text] [Related]
73. Negative nuclear expression of CDKL2 correlates with disease progression and poor prognosis of glioma.
Yi R; Yang S; Wen E; Hu Z; Long H; Zeng Y; Wang X; Huang X; Liao Y; Luo M; Wang J; Zhou M; Wang W; Xu A; Lin J; Wu Z; Song Y
Int J Clin Exp Pathol; 2018; 11(2):712-719. PubMed ID: 31938157
[TBL] [Abstract][Full Text] [Related]
74. Metabolic Alterations Related to Glioma Grading Based on Metabolomics and Lipidomics Analyses.
Yu D; Xuan Q; Zhang C; Hu C; Li Y; Zhao X; Liu S; Ren F; Zhang Y; Zhou L; Xu G
Metabolites; 2020 Nov; 10(12):. PubMed ID: 33255474
[TBL] [Abstract][Full Text] [Related]
75. Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.
Matarazzo S; Melocchi L; Rezzola S; Grillo E; Maccarinelli F; Giacomini A; Turati M; Taranto S; Zammataro L; Cerasuolo M; Bugatti M; Vermi W; Presta M; Ronca R
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480336
[TBL] [Abstract][Full Text] [Related]
76. Expression of redox sensing factor Nrf2 in lung macrophages and type II pneumocytes as a prognostic factor in pneumothorax recurrence.
Chiu WC; Lee YL; Chou SH; Lee YC; Su YH; Hou YA; Chiang HH; Yin HL; Hu SC; Huang MY; Huang CJ; Yuan SF
J Thorac Dis; 2017 Aug; 9(8):2498-2509. PubMed ID: 28932556
[TBL] [Abstract][Full Text] [Related]
77. MMP2 is associated with glioma malignancy and patient outcome.
Sincevičiūtė R; Vaitkienė P; Urbanavičiūtė R; Steponaitis G; Tamašauskas A; Skiriutė D
Int J Clin Exp Pathol; 2018; 11(6):3010-3018. PubMed ID: 31938426
[TBL] [Abstract][Full Text] [Related]
78. PTX3 promotes breast cancer cell proliferation and metastasis by regulating PKCζbreast cancer, pentraxin 3, protein kinase Cζ, proliferation, metastasis.
Wu J; Yang R; Ge H; Zhu Y; Liu S
Exp Ther Med; 2024 Mar; 27(3):124. PubMed ID: 38410189
[TBL] [Abstract][Full Text] [Related]
79. Role of long pentraxin PTX3 in cancer.
Li D; Hao Z; Nan Y; Chen Y
Clin Exp Med; 2023 Dec; 23(8):4401-4411. PubMed ID: 37438568
[TBL] [Abstract][Full Text] [Related]
80. Insights into the Relationship between Pentraxin-3 and Cancer.
Bogdan M; Meca AD; Turcu-Stiolica A; Oancea CN; Kostici R; Surlin MV; Florescu C
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
